RenovoRx, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

145.8 k

Shareholding (Jun 2025)

FII

0.06%

Held by 2 FIIs

DII

94.08%

Held by 7 DIIs

Promoter

0.00%

How big is RenovoRx, Inc.?

22-Jun-2025

As of Jun 18, RenovoRx, Inc. has a market capitalization of 49.37 million, with net sales of 0.24 million and a net profit of -10.16 million over the latest four quarters. The company reported shareholder's funds of 4.48 million and total assets of 8.20 million as of Dec 24.

What does RenovoRx, Inc. do?

22-Jun-2025

RenovoRx, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $2 million as of March 2025, with a market cap of $49.37 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -84.75%.

Is RenovoRx, Inc. technically bullish or bearish?

20-Sep-2025

As of September 10, 2025, RenovoRx, Inc. shows a mildly bearish technical trend, with mixed signals from MACD and moving averages, despite outperforming the S&P 500 recently.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 42 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.15

Return on Equity

-101.49%

Price to Book

3.93

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Jun 2025)

Net Profit:

-3 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-24.0%

6 Months

-30.66%

1 Year

-25.2%

2 Years

46.15%

3 Years

-49.47%

4 Years

-85.27%

5 Years

0.0%

RenovoRx, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is RenovoRx, Inc. technically bullish or bearish?

As of 10 September 2025, the technical trend for RenovoRx, Inc. has changed from sideways to mildly bearish. The weekly MACD indicates a mildly bearish stance, while the monthly MACD shows a mildly bullish signal, creating a mixed outlook. The daily moving averages are also mildly bearish. The Bollinger Bands present a mildly bullish signal on the weekly and bullish on the monthly, which contrasts with the overall bearish trend. The KST is mildly bearish on the weekly and bearish on the monthly, and the OBV shows a bullish signal on the monthly but no trend on the weekly. In terms of performance, RenovoRx has outperformed the S&P 500 over the past week and month, with returns of 1.61% and 34.04% respectively, while it has underperformed year-to-date and over three years. Overall, the current technical stance is mildly bearish, driven primarily by the daily moving averages and the weekly MACD....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

13.51%

EBIT Growth (5y)

-206.36%

EBIT to Interest (avg)

-10.06

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.10

Sales to Capital Employed (avg)

0.03

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

31.88%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.86

EV to EBIT

-3.13

EV to EBITDA

-3.13

EV to Capital Employed

-27.37

EV to Sales

36.35

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-84.75%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 4 Schemes (5.86%)

Foreign Institutions

Held by 2 Foreign Institutions (0.06%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -20.83% vs -4.35% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.70",
          "val2": "-3.00",
          "chgp": "10.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "0.50",
          "chgp": "-160.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.90",
          "val2": "-2.40",
          "chgp": "-20.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6,346.00%",
          "val2": "0.00%",
          "chgp": "-634.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 13.73% vs -3.03% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.00",
          "val2": "-11.40",
          "chgp": "3.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.80",
          "val2": "1.10",
          "chgp": "63.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.80",
          "val2": "-10.20",
          "chgp": "13.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-255,116.30%",
          "val2": "0.00%",
          "chgp": "-25,511.63%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.40

0.00

Operating Profit (PBDIT) excl Other Income

-2.70

-3.00

10.00%

Interest

0.00

Exceptional Items

-0.30

0.50

-160.00%

Consolidate Net Profit

-2.90

-2.40

-20.83%

Operating Profit Margin (Excl OI)

-6,346.00%

0.00%

-634.60%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -20.83% vs -4.35% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-11.00

-11.40

3.51%

Interest

0.00

Exceptional Items

1.80

1.10

63.64%

Consolidate Net Profit

-8.80

-10.20

13.73%

Operating Profit Margin (Excl OI)

-255,116.30%

0.00%

-25,511.63%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 13.73% vs -3.03% in Dec 2023

All Annual Results

Company CV

About RenovoRx, Inc.

RenovoRx, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

RenovoRx, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is RenovoRx, Inc.?

Watch in Real-Time

What does RenovoRx, Inc. do?

Is RenovoRx, Inc. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is RenovoRx, Inc. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Jun 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About RenovoRx, Inc.

Company Coordinates